Tempus AI Inc. (NASDAQ:TEM) stock is surging over 11% on Friday at the time of publication.
The price movement is primarily driven by a broader AI-healthcare technology sector rally sparked by stellar earnings and guidance from industry peers like Doximity Inc. (NYSE:DOCS).
The Nasdaq is up 0.86% while the S&P 500 has gained 0.47%, and TEM’s move is also outpacing the Healthcare sector’s 0.3% gain.
Peer Earnings Drive Sector Momentum
Doximity reported fiscal first-quarter revenue of $156.6 million on Friday, beating consensus analyst estimates of $151.7 million.
During the earnings call, CEO Jeff Tangney said AI is "up-leveling our business across the board" and noted the market opportunity unlocked by AI "has been a real surprise and upside for us."
CellCarta Collaboration Details
On Thursday, August 6, CellCarta announced a strategic collaboration with Tempus AI.
CellCarta added Tempus to its CDx Commercialization Lab Network as its second commercial laboratory partner to support oncology companion diagnostics offerings to biopharma sponsors.
Critical Technical Levels for TEM Stock
TEM is trading about 5% above its 20-day SMA ($48.15), which signals the near-term trend has turned up, but it’s still trading about 13% below its 200-day SMA ($58.31), keeping the longer-term trend pressure intact. The stock is also sitting just 1.1% below its 50-day SMA ($51.11), making that zone an immediate "line in the sand" for whether this bounce can turn into a sustained trend.
RSI is the cleaner momentum read right now, sitting at 53.87, which points to neutral momentum rather than an overbought squeeze.
The bigger backdrop is still mixed-to-bearish on longer timeframes: the 20-day SMA remains below the 50-day SMA, and the death cross (50-day below 200-day) that formed in January suggests rallies can still run into overhead supply. Traders will also remember the stock’s major turning points—overbought conditions in October 2025 and oversold conditions in March—as context for how quickly sentiment has swung in this name.
- Key Support: $46.50
- Key Resistance: $54.50
TEM Price Action: Tempus AI shares were up 10.49% at $50.95 at the time of publication on Friday, according to Benzinga Pro data.
Photo: T. Schneider / Shutterstock
Login to comment